NCT04872608 - A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer | Biotech Hunter

Timeline

Start Date

September 9, 2021

Primary Completion Date

April 25, 2023

Study Completion Date

April 25, 2023

Conditions

Metastatic Breast CancerUnresectable Breast Cancer

Interventions

DRUG

Letrozole

Letrozole will be given daily on days 1-28.

DRUG

Palbociclib

Palbociclib will be given daily on days 1-21 and held on days 22-28, as per standard FDA-approved dosing guidelines.

DRUG

Onapristone ER

Onapristone will be given daily on days 1-28.

Trial Locations (1)

Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison